Home › NCT04122313
Post-contracture Release Radiation for Dupuytren's Disease
RecruitingObservational study
Efficacy of Post-contracture Release Radiation for the Treatment of Dupuytren's Disease
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnoses of Dupuytren's disease * English-speaking Exclusion Criteria: \- Patients with Dupuytren's disease who are not currently seeking treatment
About the study
To determine if the clinical impression of clinicians, ie that patients are improving with the current treatment pathway for Dupuytren's (contracture release followed by radiation), can be substantiated with scientific evidence.
What is being tested
- Evaluation of Dupuytren's Disease Treatment (other)
Sponsor: University of Minnesota · Participants: 50 · Started: May 31, 2019
Contact the study team
- Leslie Chang · Phone: 612-273-6014
Official record on ClinicalTrials.gov — NCT04122313
Locations in the U.S.
| Minnesota | University of Minnesota, Minneapolis |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.